LEYTEVU

EUIPO EUIPO 2023 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark LEYTEVU was filed as Word mark on 03/06/2023 at the European Union Intellectual Property Office.
It was registered as a trademark on 06/23/2023. The current status of the mark is "Trademark registered".

Trademark Details Last update: May 15, 2024

Trademark form Word mark
File reference 018844509
Application date March 6, 2023
Publication date March 16, 2023
Entry date June 23, 2023
Expiration date March 6, 2033

Trademark owner

One Amgen Center Drive
91320-1799 Thousand Oaks,
US

Trademark representatives

2Amsterdam Eduard van Beinumstraat 10 3rd Floor 1077 CZ Amsterdam NL

goods and services

5 Pharmaceutical preparations; pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure

Trademark history

Date Document number Area Entry
November 6, 2023 Change Representative, Published

ID: 11018844509